MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-12-2026
MTBC EPS Ratio 2011-2026 | MTBC
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio MTBC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.1 | -0.28 | -4.11 | -0.67 | -0.77 | -1.79 | -0.6 | -0.59 | -0.69 | -0.95 | - | -0.64 | -0.03 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.1 | -4.11 | -0.918 |
Quarterly EPS Ratio MTBC
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.04 | -0.04 | - | -0.04 | -0.14 | -0.1 | - | -0.42 | -0.37 | -0.28 | - | -0.18 | -0.07 | -0.19 | - | -0.15 | -0.27 | -0.36 | - | -0.46 | -0.65 | -0.42 | - | -0.14 | -0.19 | -0.15 | - | -0.25 | -0.09 | -0.06 | - | -0.14 | -0.2 | -0.29 | - | -0.17 | -0.15 | -0.21 | - | -0.13 | -0.15 | -0.12 | - | -0.34 | -0.06 | -0.08 | - | -0.03 | -0.02 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.04 | -0.65 | -0.185 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Health information services industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-1.72 | - | 0.29 % | $ 206 M |  USA |
 |
Phreesia
PHR
|
-2.51 | $ 11.28 | - | $ 615 M | USA |
 |
Change Healthcare
CHNG
|
-0.18 | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
1.86 | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
-5.96 | $ 5.63 | -2.26 % | $ 90.3 M | USA |
 |
Computer Programs and Systems
CPSI
|
-3.15 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
-0.39 | - | - | $ 2.94 B | USA |
 |
Schrödinger
SDGR
|
-1.41 | $ 11.4 | -1.47 % | $ 837 M | USA |
 |
iCAD
ICAD
|
-0.21 | - | - | $ 102 M | USA |
 |
Teladoc Health
TDOC
|
-1.14 | $ 5.57 | 2.77 % | $ 982 M | USA |
 |
NextGen Healthcare
NXGN
|
0.14 | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
-1.64 | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
0.22 | - | - | $ 2.33 B | USA |
 |
Omnicell
OMCL
|
0.27 | $ 34.94 | 1.39 % | $ 1.61 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-1.03 | $ 7.18 | 5.9 % | $ 123 M | USA |
 |
Evolent Health
EVH
|
-0.2 | $ 2.27 | 0.89 % | $ 213 M | USA |
 |
GoodRx Holdings
GDRX
|
0.04 | $ 2.06 | 0.98 % | $ 795 M | USA |
 |
SCWorx Corp.
WORX
|
-0.78 | $ 0.13 | 1.5 % | $ 190 K | USA |
 |
Signify Health
SGFY
|
-3.27 | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
-1.86 | - | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
-0.51 | - | - | $ 161 M | USA |
 |
Zhongchao
ZCMD
|
-0.12 | $ 1.8 | -0.55 % | $ 9.37 M |  China |
 |
Allscripts Healthcare Solutions
MDRX
|
1.03 | - | -10.39 % | $ 886 M | USA |
 |
Health Catalyst
HCAT
|
-2.55 | $ 1.1 | 0.46 % | $ 76.9 M | USA |
 |
NantHealth
NH
|
-8.8 | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
2.5 | $ 82.47 | 0.45 % | $ 7.1 B | USA |
 |
HealthStream
HSTM
|
0.66 | $ 21.23 | 1.24 % | $ 645 M | USA |
 |
10x Genomics
TXG
|
-2.18 | $ 20.91 | 5.55 % | $ 2.45 B | USA |
 |
Streamline Health Solutions
STRM
|
-2.53 | - | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-6.07 | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
0.12 | $ 17.75 | -1.66 % | $ 1.52 B | USA |
 |
Veeva Systems
VEEV
|
5.55 | $ 178.11 | -0.56 % | $ 29.2 B | USA |